350) Treatment can be surgical or percutaneous. |
351) While DES treatment can accelerate the growth of ute |
352) a decreasing trend along with increase in treatment concentration and almost no dete |
353) d fish increased with the increase in the treatment concentration and treatment time |
354) We evaluated all ART treatment cycles during 7 consecutive year |
355) om assisted reproductive technology (ART) treatment cycles. |
356) In addition, treatment effects and subgroups can be mod |
357) atification provides a way to think about treatment effects conditional on post-rand |
358) pared with those in the unsupervised self-treatment group, had significantly lower r |
359) In the treatment group, LPT was applied with an e |
360) Sub -: acute ZnO NPs treatment induced no significant increase |
361) st, we found that acute and delayed ChABC treatment induced recovery of impaired mot |
362) frequent case in dental practice, but its treatment is challenging because of its im |
363) Our initial experience indicates that the treatment is simple, safe and effective bu |
364) These results suggest that bendiocarb treatment leads to increased cell death, l |
365) This study demonstrates that HA treatment leads to increases in both Hsp90 |
366) ults indicated that CVN (only at 25 mg/L) treatment led to an increase in the total |
367) (at concentrations higher than 100 mg/L) treatment led to an increase in the total |
368) Surgical treatment may consist of local excisions a |
369) Therefore, MI prognosis and treatment may differ according to coeliac |
370) Patients attending a psychiatric day treatment program (N = 218) completed meas |
371) ng, family-focused prevention, and family treatment program types within the context |
372) tate the comparison of current and future treatment protocols used for companion ani |
373) y compare outcome measures across various treatment protocols. |
374) d homework adherence, to parent and child treatment response and explored whether ea |
375) m development, progression, severity, and treatment response in LB disorders. |
376) MCT has been used specifically to manage treatment-resistant schizophrenia patients |
377) We report the case of a patient with treatment-resistant schizophrenia who resp |
378) Phosphoric acid treatment seems the most promising surface |
379) g to the severity of the burn, the second treatment seems to be the most appropriate |
380) UD treatment significantly decreased the elev |
381) In addition, A779 treatment significantly suppressed the car |
382) h zonal chondrocytes and current clinical treatment strategies do not reflect these |
|